Over the course of 2021 the off-patent industry saw several high-level executive changes, with many familiar faces transitioning to new roles.
Several senior Sandoz staff shuffled around the company’s upper management, alongside new hires joining from the likes of Teva as well as employees departing to pastures new – including rivals Hikma and Fresenius Kabi – while the